← Open Payments lookup

YUNYING CHEN: Open Payments

NPI 1558944520 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$32,435 in 81 payments from 15 companies in 2025. Trend: 2023 $17,213 · 2024 $29,794 · 2025 $32,435

Speaker / faculty: $14,765Travel & lodging: $6,576Consulting: $6,375Honoraria: $2,644Food & beverage: $2,032Education: $43
CompanyPaymentsAmount
PFIZER INC.29$21,288
Rigel Pharmaceuticals, Inc.11$7,890
Autolus Inc4$2,159
Janssen Biotech, Inc.20$512
Incyte Corporation1$125
Daiichi Sankyo Inc.4$111
AstraZeneca Pharmaceuticals LP3$99
ABBVIE INC.2$60
Takeda Pharmaceuticals U.S.A., Inc.1$35
Secura Bio, Inc.1$30

Products named: ELREXFIO, REZLIDHIA, CARVYKTI, TALVEY, RYBREVANT, Niktimvo, Vanflyta, EPKINLY.

Industry payments across CA — which companies pay providers there.